Unimark is a vertically integrated medical company focused on the development of affordable low-cost drugs in various therapeutic segments, such as: respiratory, cardiovascular, anti-infectious drugs, for the central nervous system, for customers around the world.
The company believes in introducing affordable, universal formulations that create a warm relationship between the company's customers and the global market as a whole.
Unimark has a diverse business portfolio spanning healthcare products ranging from diagnostics, devices, finished products, cosmeceuticals, animal products and active pharmaceutical ingredients.